Table 1 Affinity (KD), PK, and PD parameters of antibodies dosed in mouse models

From: Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier

Study

Fc Variant

Affinity (KD) at pH6.0 (nM)

Affinity (KD) at pH7.4 (nM)

Serum Cmaxa

Serum AUCa

Brain Cmaxa

Brain AUCa

Brain:Serum Ratio %

WT mice hIgG1 (KD to mFcRn)

anti-BACE1 WT

238

6940

1.0

1.0

1.0

1.0

0.23

anti-BACE1 YTE

14.8

836

1.4

0.7

3.2

4.0

1.23

anti-gD WT

ND

ND

1.8

1.3

1.4

1.5

0.26

hFcRn mice hIgG1 (KD to hFcRn)

anti-BACE1 WT

1012

>10000

1.0

1.0

1.0

1.0

0.25

anti-BACE1 YTE

105

>10000

1.8

1.6

0.8

0.9

0.14

anti-gD WT

ND

ND

1.6

1.6

1.3

1.3

0.20

WT mice mIgG2a (KD to mFcRn)

WT

1380

>10000

1.0

1.0

1.0

1.0

0.12

M252F

74

3320

1.0

1.0

1.8

1.9

0.23

M252Y

16

826

1.0

0.6

3.2

3.0

0.58

M252Y.Q309T

6.2

308

1.0

0.3

4.9

3.4

1.26

hFcRn mice hIgG1 (KD to hFcRn)

anti-BACE1 WT

1012

>10000

1.0

1.0

1.0

1.0

0.04

anti-BACE1 YY

13

981

1.5

0.5

2.0

1.5

0.12

anti-BACE1 YQAY

6.9

234

1.1

0.7

5.2

4.3

0.27

  1. Affinities (KD) to mouse and human FcRn measured at pH 6.0 and 7.4 by SPR. Also reported are the calculated fold changes in IgG Cmax and AUC(0-7d) relative to WT Fc for serum and brain. The Brain:Serum Ratio % reports the percentage of antibody measured in the brain relative to antibody measured in serum.
  2. a Values relative to WT, ND not done